United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
306.83
-1.18 (-0.38%)
May 9, 2025, 11:12 AM - Market open

United Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
2,9942,8772,3281,9361,6861,483
Upgrade
Revenue
2,9942,8772,3281,9361,6861,483
Upgrade
Revenue Growth (YoY)
19.84%23.63%20.20%14.88%13.63%2.38%
Upgrade
Cost of Revenue
329.3309.7257.5151.6122.5108.1
Upgrade
Gross Profit
2,6652,5682,0701,7851,5631,375
Upgrade
Selling, General & Admin
666.1640.4476472.8466.1421.1
Upgrade
Research & Development
525.9481408322.9410357.7
Upgrade
Operating Expenses
1,1871,121884795.7876.1778.8
Upgrade
Operating Income
1,4781,4461,186989686.9596.4
Upgrade
Interest Expense
-35.7-42.9-59.3-32.4-18.6-23.5
Upgrade
Interest & Investment Income
196.4199.1162.745.216.728.6
Upgrade
Other Non Operating Income (Expenses)
-1.4-1.4-27.3-38.343.826.4
Upgrade
EBT Excluding Unusual Items
1,6371,6011,262963.5728.8627.9
Upgrade
Gain (Loss) on Sale of Investments
-1.9915.8-1.7-2.316.4
Upgrade
Asset Writedown
---3.6-11.2-132.6-5.4
Upgrade
Legal Settlements
-71.1-71.1----
Upgrade
Pretax Income
1,5641,5391,274950.6593.9638.9
Upgrade
Income Tax Expense
353.2343.9289.5223.3118.1124.1
Upgrade
Net Income
1,2111,195984.8727.3475.8514.8
Upgrade
Net Income to Common
1,2111,195984.8727.3475.8514.8
Upgrade
Net Income Growth
15.25%21.36%35.41%52.86%-7.58%-
Upgrade
Shares Outstanding (Basic)
454547464544
Upgrade
Shares Outstanding (Diluted)
484950494745
Upgrade
Shares Change (YoY)
-3.02%-2.41%2.47%2.54%6.05%1.83%
Upgrade
EPS (Basic)
27.1026.4421.0415.9810.6011.65
Upgrade
EPS (Diluted)
25.1024.6419.8115.0010.0611.54
Upgrade
EPS Growth
18.87%24.38%32.07%49.10%-12.83%-
Upgrade
Free Cash Flow
1,1291,081747.6663.7477.4696.4
Upgrade
Free Cash Flow Per Share
23.4022.2815.0413.6910.0915.61
Upgrade
Gross Margin
89.00%89.24%88.94%92.17%92.73%92.71%
Upgrade
Operating Margin
49.35%50.26%50.96%51.08%40.75%40.21%
Upgrade
Profit Margin
40.44%41.53%42.31%37.56%28.23%34.71%
Upgrade
Free Cash Flow Margin
37.69%37.55%32.12%34.28%28.32%46.95%
Upgrade
EBITDA
1,5551,5191,2391,040736.8646.3
Upgrade
EBITDA Margin
51.93%52.78%53.24%53.73%43.71%43.57%
Upgrade
D&A For EBITDA
77.372.553.251.349.949.9
Upgrade
EBIT
1,4781,4461,186989686.9596.4
Upgrade
EBIT Margin
49.35%50.26%50.96%51.08%40.75%40.21%
Upgrade
Effective Tax Rate
22.59%22.35%22.72%23.49%19.89%19.42%
Upgrade
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q